Literature DB >> 10710575

Should treatment recommendations for lipid lowering drugs be based on absolute coronary risk or risk reduction?

S Ramachandran1, J M French, M P Vanderpump, P Croft, R H Neary.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10710575      PMCID： PMC27309          DOI： 10.1136/bmj.320.7236.677

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  5 in total

Review 1.  Blood pressure, antihypertensive drug treatment and the risks of stroke and of coronary heart disease.

Authors:  R Collins; S MacMahon
Journal:  Br Med Bull       Date:  1994-04       Impact factor: 4.291

2.  Thrombosis prevention trial: randomised trial of low-intensity oral anticoagulation with warfarin and low-dose aspirin in the primary prevention of ischaemic heart disease in men at increased risk. The Medical Research Council's General Practice Research Framework.

Authors: 
Journal:  Lancet       Date:  1998-01-24       Impact factor: 79.321

3.  West of Scotland Coronary Prevention Study: identification of high-risk groups and comparison with other cardiovascular intervention trials.

Authors: 
Journal:  Lancet       Date:  1996-11-16       Impact factor: 79.321

4.  By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease?

Authors:  M R Law; N J Wald; S G Thompson
Journal:  BMJ       Date:  1994-02-05

5.  Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group.

Authors:  J Shepherd; S M Cobbe; I Ford; C G Isles; A R Lorimer; P W MacFarlane; J H McKillop; C J Packard
Journal:  N Engl J Med       Date:  1995-11-16       Impact factor: 91.245
  5 in total
  2 in total

1.  Risk in cardiovascular disease. Merit of using risk reduction rather than absolute risk for lipid lowering drugs.

Authors:  R Neary; S Ramachandran
Journal:  BMJ       Date:  2000-07-15

2.  Guidelines on preventing cardiovascular disease in clinical practice.

Authors:  R Jackson
Journal:  BMJ       Date:  2000-03-11
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.